Financials data is unavailable for this security.
View more
Year on year Thalys Medical Technology Group Corp had revenues fall -13.10% from 2.31bn to 2.01bn, though the company grew net income from a loss of 154.42m to a smaller loss of 158.57m.
| Gross margin | 18.51% |
|---|---|
| Net profit margin | -10.97% |
| Operating margin | -13.02% |
| Return on assets | -6.04% |
|---|---|
| Return on equity | -17.18% |
| Return on investment | -11.27% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Thalys Medical Technology Group Corp fell by 73.26m. However, the company earned 125.89m from its operations for a Cash Flow Margin of 6.28%. In addition the company generated 15.19m cash from investing, though they paid out 214.31m more in financing than they received.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 5.31 |
|---|---|
| Tangible book value per share | 4.78 |
More ▼
Balance sheet in CNYView more
| Current ratio | 1.66 |
|---|---|
| Quick ratio | 1.43 |
| Total debt/total equity | 1.06 |
|---|---|
| Total debt/total capital | 0.4974 |
More ▼
Growth rates in CNY
Year on year, growth in earnings per share excluding extraordinary items dropped -3.80%.
| Div yield(5 year avg) | 0.11% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -79.83 |
More ▼
